Bionime Corp (4737)

Taiwan

Currency in TWD

73.50

0.00(0.00%)

Closed·30/07

Fair Value

Unlock Value

Day's Range

73.50

74.90

52 wk Range

47.45

80.50

4737 Financial Summary

A brief financial summary of Bionime Corp as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-36.06

Price/Book2.6

Debt / Equity163.73%

Return on Equity-7.03%

Dividend Yield2.72%

EBITDA652.00K

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

1,668.59

1,849.92

2,210.59

1,755.57

1,933.75

Gross Profit

aa.aa

749.13

783.13

1,004.13

715.65

768.38

Operating Income

aa.aa

21.12

75.29

131.42

-13.34

-155.19

Net Income

aa.aa

62.43

87.41

91.03

6.21

-127.22

Balance Sheet

Total Assets

aa.aa

4,485.05

4,563.88

4,983.06

5,300.58

5,781.27

Total Current Liabilities

aa.aa

1,241.05

1,329.43

1,410.96

1,609

2,311

Total Equity

aa.aa

2,070.78

2,076.08

2,080.54

1,993.2

1,889.02

Cash Flow

Levered Free Cash Flow

aa.aa

-67.03

-52.71

-194.16

-263.23

-262.26

Cash from Operations

aa.aa

217.56

269.72

142.29

203.44

19.53

Cash from Investing

aa.aa

-330.77

-288.07

-312.26

-435.26

-336.9

Cash from Financing

aa.aa

96.33

-69.3

113.64

420.41

217.3

Net Change in Cash

aa.aa

-16.31

-90.16

-38.6

177.33

-70.59

* In Millions of TWD (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS -2.21%

Dividend Yield

2.72%

Industry Median 3.49%

Annualised payout

2.00

Paid annually

5-Years Growth

Growth Streak

Unlock

Earnings

Latest Release

May 30, 2025

EPS / Forecast

-0.21 / --

Revenue / Forecast

481.44M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Bionime's earnings for the latest quarter?

The Bionime EPS (TTM) is -2.21. Bionime reported sales of 481.44, net income of -12.57, and EPS of -0.21 for the latest quarter.

What was Bionime's net income for the latest quarter?

Bionime's net income for the latest quarter was -12.57.

How did Bionime's performance compare year-over-year in the latest quarter?

The company's revenue moved from 502.22 in the previous quarter to 481.44 in the latest quarter, and net income moved from -32.52 to -12.57 compared to the previous quarter.

What is Bionime's net profit margin on a TTM basis?

Bionime's trailing twelve months (TTM) net profit margin is -6.58%.

How does Bionime's debt to equity ratio compare to industry standards?

Bionime's total debt-to-equity ratio is 163.73%.

What is Bionime's return on investment on a TTM basis?

Bionime's trailing twelve months (TTM) return on investment (ROI) is -7.03%.

Did Bionime gain or lose cash last quarter?

In the latest quarter, Bionime's net change in cash was 18.67 million.

What were Bionime's total assets and liabilities in the latest quarter?

As of the latest quarter, Bionime reported total assets of 5,705.75 million and total liabilities of 2,003.82 million.

How has Bionime's total revenue grown this year?

Bionime's total revenue was 502.22 in the previous quarter and 481.44 in the latest quarter.

What is Bionime's gross margin on a TTM basis?

Bionime's trailing twelve months (TTM) gross margin is 38.35%.

What was Bionime's revenue per share for the latest quarter?

Bionime's revenue per share for the latest quarter was 43.96.

NSE 30

5,057.25

-53.01

-1.04%

NSE All Share

137,913.27

-1,365.40

-0.98%

US 30

44,631.80

+170.5

+0.38%

US 500

6,426.20

+63.3

+0.99%

FTSE 100

9,168.55

+31.61

+0.35%

DAX

24,332.19

+59.54

+0.25%

South Africa Top 40

91,386.57

-211.06

-0.23%

Market Movers

Name	Last	Chg. %	Vol.
First HoldCo	33.70	-3.44%	5.22M
Lafarge Africa	152.00	+0.66%	5.17M
Transcorp	51.500	+0.98%	3.46M
MTN Nigeria	489.10	+3.82%	1.74M
Guaranty Trust Holding	101.80	-0.15%	1.50M
Betaglas	400.00	+6.95%	425.40K
Aradel Holdings	520.50	+1.24%	313.18K

Name	Last	Chg. %	Vol.
Chellarams	11.55	+10.00%	9.30K
UAC Of Nigeria	80.30	+10.00%	693.36K
Guinness Nigeria	117.05	+9.96%	8.58K
Betaglas	400.00	+6.95%	425.40K
Caverton Offshore Support	8.990	+9.90%	2.06M
Mecure Industries	15.85	+9.69%	332.23K
Juli	10.20	+9.68%	2.06K

Name	Last	Chg. %	Vol.
Transcorp Power	288.00	-10.00%	3.65K
Geregu Power	1,027.40	-10.00%	562.00
Chams	2.85	-5.00%	4.81M
Conoil	211.10	-9.98%	1.47K
Cileasing	6.35	-9.93%	3.67M
Mansard Ins	11.750	-9.62%	2.95M
Total Nig	638.00	-9.50%	15.18K

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	489.10	+3.82%	1.73M
Guaranty Trust Holding	101.80	-0.15%	1.50M
Okomu Oil Palm	1,150.00	+9.52%	5.42K
Initiates	14.80	-1.33%	145.66K
Lafarge Africa	158.00	+4.64%	5.17M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa A A	513.00	+38.81%	712.10
Aaaaa Aa Aaaaaa A	5,570.00	+30.99%	7,296.14
Aaaaaa Aa Aaa	66.50	+25.53%	83.48
Aaaaaaaa Aaaaaa	130.00	+24.29%	161.58

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Bionime Corp (4737)

4737 Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Bionime's earnings for the latest quarter?

What was Bionime's net income for the latest quarter?

How did Bionime's performance compare year-over-year in the latest quarter?

What is Bionime's net profit margin on a TTM basis?

How does Bionime's debt to equity ratio compare to industry standards?

What is Bionime's return on investment on a TTM basis?

Did Bionime gain or lose cash last quarter?

What were Bionime's total assets and liabilities in the latest quarter?

How has Bionime's total revenue grown this year?

What is Bionime's gross margin on a TTM basis?

What was Bionime's revenue per share for the latest quarter?

Trending Stocks